@lyfjos.com
Aimed at the needs of researchers to extend the scope of their discoveries, Lyfjos builds up a portfolio of promising IP and bringing them to market.
๐ข
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
About
Description
Lyfjosยฎ is a brand that partners with researchers in generating, assessing, and commercializing intellectual property and derived products. With a focus on blood disorders, Lyfjos aims to develop inexpensive and robust treatments and diagnosing tools that can be easily accessible worldwide. In collaboration with the University Hospital of Zurich and the University of Zurich, Lyfjos has successfully conducted a clinical phase II study on the use of the drug Memantine for Sickle Cell Disease patients, showing promising results.
Recognizing the need for affordable medicine and increased knowledge in patient examination and treatment, Lyfjos has formed a leading scientific and medical network through projects with renowned groups in red blood cell research. To address the scope of patient treatment, Lyfjos has partnered with the Red Blood Cell Network, offering diagnostic services, treatment advice, and knowledge to professionals, doctors, and researchers. By expanding its scope from IP transfer to comprehensive patient treatment services, Lyfjos contributes to improving care for uncommon diseases and aims to make a positive impact on the lives of patients worldwide
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere ๐
All services online
Top brand categories